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Objectives Our aim was to compare ventricular septal defect (VSD) size
and morphology obtained by 2D-TTE with these obtained by three-dimen-
sional transthoracic echocardiography (3D-TTE), and correlate morphological
parameters with shunt severity.
Background VSD is assessed classically by bi-dimensional transthoracic
echocardiography (2D-TTE) which seems underestimate the defect dimen-
sions.
Methods 48 patients with muscular (22.9%) and membranous (77.1%)
VSDs were included. Patients were classified according to shunt severity.
Type 1 minor shunt, 2a moderate shunt, and 2b severe shunt. Minimal (min-
2D) and maximal (max-2D) diameters were assessed using 2D-TTE. A 3D-
TTE full volume dataset was acquired using matrix probes. Minimal (min-
3D), maximal (max-3D) diameters, systolic (sVSDA) and diastolic (dVSDA)
areas of the VSD were obtained. VSD asymmetry was expressed by max/min
diameters ratio.
Results Median age was 21.4±29.3 month-old. There were 20 VSDs with
minor shunt, 18 with moderate shunt, and 10 with severe shunt. Max-3D was
higher than Max-2D diameter (11.3±3.3 vs. 7.3±2.4). The deference was less
between min-3D and min-2D diameters (5.6±2.2 vs. 5.1±2 respectively). VSD
were asymmetric with a mean asymmetry ratio of 2.3±1.4 by 3D-TTE. Asym-
metry ratio was higher in muscular VSD than in membranous one by 3D-TTE.
Mean systolo-diastolic VSD area variation was 32%. It was significantly
higher in muscular than in membranous VSD (Median 54% versus 27%).
VSD severity was not correlated with maximal diameter, but with minimal
diameter. Better correlation was found using the defect area (sVSDA/BSA
ratio, sVSDA/AVA ratio; r=0.60, p=0.0008; r=0.63, p=0.0002). Shunt severity
was inversely correlated with the asymmetry ratio. The best parameter to pre-
dict the shunt severity was sVSDA/AVA ratio.
Conclusions 3D TTE allows a precise morphological and a quantitative
assessment of VSD. sVSDA/AVA ratio is an accurate diagnostic tool to pre-
dict the shunt severity.
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Background Prognostic value of right ventricular (RV) systolic function is
well established in cardiomyopathy or valvular disease, but few data are avai-
lable in patients undergoing cardiac surgery and the predictive value of RV
function before cardiac surgery in predicting mortality is not well established.
The aim of the present study was to evaluate the prognostic value of pre-
operative RV dysfunction carefully evaluated using a large set of echocardio-
graphic parameters (S’, RV fractional area change (RVFAC), right myocardial
performance index (RMPI), isovolumic acceleration (IVA), RV dP/dt and 2D
peak longitudinal strain) in a large population of unselected patient awaiting
cardiac surgery.
Methods We prospectively studied 396 consecutive patients referred for
cardiac surgery, in a single surgical center. Echocardiography was performed
≤24 hours before surgery and recalling assessed the survival status at 3-years
after surgery.
Results Based on S’<10cm/s and/or RVFAC<35%, 93 patients had a pre-
operative RV dysfunction. At 3-years mortality was 42/396.
The univariate Cox analysis identified all RV function parameters excepted 2D
strain as predictive factors of survival, with the strongest value for RVFAC<35%
(HR 4.8), S’<10cm/s (HR 3.8) and IVA<1,8m/s2 (HR 3.2) (all p<0.0001).
In multivariate analysis, RVFAC, S’, dP/dt and IVA were significantly asso-
ciated to the 3-years survival: this result was found in the total population, as well
as in all the quartile of population when stratified according to the Euroscore.
S’<10cm/s + RVFAC<35% + IVA<1,8m/s2 best predicted mortality at
3 years (HR 17).
Conclusions The presence of RV dysfunction before cardiac surgery esti-
mated by echo is associated with a rise of postoperative mortality, and this is
true whatever the Euroscore level. This result demonstrates the need of adding
echographic RV function assessment using a multiparametric approach before
cardiac surgery.
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Background Right ventricular (RV) function is an important determinant of
outcome in patients with pulmonary arterial hypertension (PAH). However
contribution of echocardiography in predicting prognosis is poorly defined.
Purpose Aims of the study were to (1) describe main echocardiographic
findings in an incident PAH population at baseline (2) analyze changes after
a similar period of treatment and (3) determine parameters reproducibility in
an independent echocardiography core laboratory.
Methods Incident idiopathic, familiar or anorectics PAH patients were
included in the multicentric EFORT study. All patients were assessed
conventionally and received specific therapy. A complete echocardiographic
exam including RV longitudinal systolic strain (LSS) was performed at base-
line and at four months. A systematic second reading was conducted blind for
each exam in the Marseille La Timone echocardiography core laboratory. Inter
and intra observer reproducibility was evaluated (intraclass correlation).
Results 49 patients were included in the echocardiographic substudy. At
baseline estimated right atrial pressure (RAP) was 9 mmHg (8-11), systolic
pulmonary artery pressure (sPAP) 76 mmHg (70-81), diastolic eccentricity
index (EI) 1.44 (1.29-1.59), cardiac output (CO) 4,5l/mn (4.03-4.98), right
atrial area (RAA) at 23 cm² (21-25), right ventricular fractional area shor-
tening (RVFAS) 27% (25-30), tricuspide plane annular systolic excursion
(TAPSE) 18,3mm (16.8-19.9), S tricuspid velocity (Stric) 11,1cm/s (10.0-
12.2) and RV global LSS –13.5% (–15.3 – –11.7). Revaluation at 3 months
(n=29) showed significant differences for the following parameters: RAP
(p=0.006), sPAP (p 0.001), EI (p=0.03), CO (p=0.021), TAPSE (p=0.002),
Stric (p=0.015) and RV global LSS (p=0.017); all towards improving. The
more reproducible parameters were RV global LSS (0.861), TAPSE (0.851),
Stric (0.839), RAA (0.82) and sPAP (0.79) (inter-observer inter-center ana-
lysis). Results were the same or better for inter or intra observer repro-
ducibility within the core laboratory.
Conclusion Intermediate results of the EFORT substudy support that echo-
cardiography is a simple, reproducible tool able to measure significant
changes in follow up of PAH patients receiving specific therapy.
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